2018
DOI: 10.1039/c8ay01442f
|View full text |Cite
|
Sign up to set email alerts
|

The role of peptide microarrays in biomedical research

Abstract: Peptide microarrays, comprising hundreds to thousands of different peptides on solid supports in a spatially discrete pattern, are increasingly being used as high throughput screening tools with high sensitivity in biomedical science.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 102 publications
0
8
0
Order By: Relevance
“…Alternatively, short antigenic epitopes have emerged as promising substitutes of recombinant proteins in immunoassays. Besides benefiting from well-established peptide chemistry, ease of purification, and high stability, the use of peptide epitopes provides a distinctive capacity to break down heterogeneous immune responses into almost monoclonal antibody specificities, enabling a highly differentiated serological diagnosis. , We have recently reported the discovery of four IgG-specific linear B-cell epitopes that could differentiate SARS-CoV-2 from other coronavirus infections using COVID-19 patients’ plasma samples. , These peptide epitopes are conserved within the circulating COVID-19 variants and thus have the potential to serve as highly specific affinity ligands for improved immunoassay development. In terms of assay formats, classical immunoassays are labor-intensive and require multiple reagents with long incubation, washing, and reaction steps (2–5 h) .…”
mentioning
confidence: 99%
“…Alternatively, short antigenic epitopes have emerged as promising substitutes of recombinant proteins in immunoassays. Besides benefiting from well-established peptide chemistry, ease of purification, and high stability, the use of peptide epitopes provides a distinctive capacity to break down heterogeneous immune responses into almost monoclonal antibody specificities, enabling a highly differentiated serological diagnosis. , We have recently reported the discovery of four IgG-specific linear B-cell epitopes that could differentiate SARS-CoV-2 from other coronavirus infections using COVID-19 patients’ plasma samples. , These peptide epitopes are conserved within the circulating COVID-19 variants and thus have the potential to serve as highly specific affinity ligands for improved immunoassay development. In terms of assay formats, classical immunoassays are labor-intensive and require multiple reagents with long incubation, washing, and reaction steps (2–5 h) .…”
mentioning
confidence: 99%
“…To address this issue and to facilitate high-throughput assessment of molecular interactions between venom toxin epitopes and antivenom antibody paratopes, high-density peptide microarray (hdpm) technology has recently been adapted to the field of toxinology [13][14][15]. Hdpms have long been successfully applied to a range of fields, such as enzyme inhibition, immunoassays, affinity agents for viruses, and therapeutic peptides amongst others [16]. However, the application of this technology to venom and antivenom research is relatively new [13].…”
Section: Plos Neglected Tropical Diseasesmentioning
confidence: 99%
“…Synthetic peptides mimicking the antigenic determinants of full protein antigens and acting as their minimized surrogates, offer new opportunities for the development of immunoprobes with superior characteristics in terms of ease of handling, reproducibility, costs and stability in the typical low resource setting conditions (for example storage at high humidity at RT) [11,12,13].…”
Section: Introductionmentioning
confidence: 99%